Inflammation as a Treatment Target After Acute Myocardial Infarction [1]
An editorial related to a recent randomized controlled trial suggesting a striking benefit of anti-inflammatory secondary prevention after recent myocardial events.
An editorial related to a recent randomized controlled trial suggesting a striking benefit of anti-inflammatory secondary prevention after recent myocardial events.
Links
[1] https://www.ctsnet.org/jans/inflammation-treatment-target-after-acute-myocardial-infarction
[2] https://www.ctsnet.org/home/aprotopapas
[3] https://www.nejm.org/doi/full/10.1056/NEJMe1914378
[4] https://www.ctsnet.org/taxonomy/pharmacology
[5] https://www.ctsnet.org/tags/cardiac-pharmacology
[6] https://www.ctsnet.org/taxonomy/coronary-disease-other
[7] https://www.ctsnet.org/taxonomy/coronary-disease-pci
[8] https://www.ctsnet.org/tags/myocardial-infarction
[9] https://www.ctsnet.org/categories/cardiac
[10] https://www.ctsnet.org/taxonomy2018/coronary-disease
[11] https://www.ctsnet.org/taxonomy2018/basic-science